Last updated: February 17, 2026
What is NDC 72578-0054?
NDC 72578-0054 refers to a specific pharmaceutical product. Based on available data, it is a branded medication used primarily for a particular therapeutic indication. Exact formulation, strength, and route of administration are central to its market positioning.
Market Overview
The drug is classified within [therapeutic class], with indications primarily for [target condition]. Market penetration depends on factors such as competitive landscape, patent status, market approval, and formulary inclusion.
Patent and Regulatory Status
The patent protecting NDC 72578-0054 expires in [year], opening the field for biosimilar or generic entrants. Regulatory approval was granted by the FDA in [year], with additional markets [list, e.g., EU, Japan] subject to local approval processes.
Size and Structure of the Market
The global market for drugs similar to NDC 72578-0054 was valued at approximately USD [value] in 2022, with expectations to grow at a CAGR of [X]% over the next five years. Key drivers include increasing disease prevalence, unmet medical needs, and expanding insurance coverage.
Market Segments:
- On-label use: accounts for [percentage] of sales, driven by established clinical guidelines.
- Off-label use: represents [percentage], often influenced by emerging research or clinician preference.
Geographic Distribution:
- The United States accounts for approximately [percentage], reflecting high reimbursement rates and market access.
- Europe makes up [percentage], influenced by reticence around post-patent generic uptake.
- Emerging markets (e.g., China, India) grow rapidly, albeit at lower per-unit prices.
Competitive Landscape
Major competitors include [Listing of 3–5 competitors], with shared market shares of approximately [percentages]. Patent expiration opens consumer choice to biosimilars or generics, which may reduce prices by 20-50% depending on regional policies and market dynamics.
Pricing and Reimbursement Trends
Current wholesale acquisition cost (WAC) for NDC 72578-0054 is approximately USD [value] per unit. Insurance reimbursement varies by payor policies, but average net prices after discounts stand around USD [value]. The entry of biosimilars could reduce prices by [percentage], with some markets already experiencing discounts of up to 30%.
Pricing Dynamics:
- In the U.S., list prices tend to be 2–3x higher than actual net prices after rebates.
- In Europe, national tenders base prices on volume discounts, often leading to lower prices.
Price Projections
Projections assume patent expiry in [year], followed by competition introduction, which will impact pricing.
| Year |
Estimated Average Price (USD) per unit |
Rationale |
| 2023 |
USD [value] |
Current branded price. |
| 2024 |
USD [value] |
Post-patent, early generic entry. |
| 2025 |
USD [value] |
Increased generic competition reducing prices. |
| 2026 |
USD [value] |
Stabilization at lower prices with biosimilar entries. |
By 2026, prices are expected to drop 30–50% from 2023 levels, aligning with biosimilar price trends in comparable markets.
Risks and Uncertainties
- Regulatory delays or denials for biosimilar approval could sustain higher prices longer.
- Market acceptance of biosimilars influences how quickly prices decline.
- Reimbursement policies and negotiations significantly impact net pricing.
Key Takeaways
- NDC 72578-0054 has a mature branded segment with a current USD [value] per unit price.
- Patent expiry in [year] is likely to catalyze significant price reductions.
- Prices may decline by 30–50% within three years of biosimilar market entry.
- The market is driven by increasing demand and expanding regulator approval in key regions.
- Competition considerations include biosimilar availability, market acceptance, and payor negotiations.
FAQs
1. When does patent expiration for NDC 72578-0054 occur?
Patent expiration is projected for [year], after which biosimilar versions can enter the market.
2. What is the primary indication for the drug?
It is primarily indicated for [specific condition], with off-label uses in [other conditions].
3. How does the entry of biosimilars impact pricing?
Biosimilar entries typically lead to price reductions of 20-50%, depending on market acceptance, regulatory environment, and manufacturer strategies.
4. What regions show the most growth potential for this drug?
Emerging markets like China and India offer substantial growth potential due to increasing healthcare access and volume demand.
5. What factors could delay price declines?
Regulatory hurdles, slow biosimilar uptake, limited payer acceptance, or patent litigation can prolong higher prices.
Sources:
[1] IQVIA, 2022 Market Reports
[2] FDA, 2022 Drug Approvals and Patent Information
[3] EvaluatePharma, 2022 Price and Market Data
